Search
for
Sort by
Research 541–570 of 1000+
- Most Baricitinib Responders Achieved Full Scalp Hair Regrowth: Findings from Adult and Paediatric BRAVE-AA Trials
- A review on phytotherapeutic approaches for scalp and hair wellness by herbal onion oil
- A review on phytotherapeutic approaches for scalp and hair wellness by herbal onion oil
- Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Dermatoscopic of pseudocyst of the scalp
- Telogen effluvium after contact dermatitis in the scalp * Eflúvio telógeno após dermatite de contato no couro cabeludo *
- SIRT1 downregulation provokes immune-inflammatory responses in hair follicle outer root sheath cells and may contribute to development of alopecia areata
- The Efficacy of Excimer Laser in the Treatment of Alopecia Areata
- Dermoscopic Approach to a Small Round to Oval Hairless Patch on the Scalp
- Clinico-epidemiological study of alopecia areata
- Alopecia areata: Impressive results using low-level laser therapy
- Insights in Trichoscopy: The Utility of Ultraviolet‐Induced Fluorescence Dermoscopy in Diagnosis of Alopecia Areata and Tinea Capitis in the Pediatric Population
- Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO)
- BH02 Overcoming genetic drivers in alopecia areata: hair regrowth in a patient with the <i>AIRE</i> gene mutation treated with ruxolitinib
- Overcoming hurdles: Side effects with old drugs and achieving success with novel drug in alopecia areata
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
- 21 Adipose stem cell exosome (ASCE): next generation regenerative aesthetics & therapeutics for scalp & hair
- Sustained hair regrowth with ritlecitinib to Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study
- A rare primary subcutaneous panniculitis-like T-cell lymphoma with scalp involvement associated with lupus panniculitis
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Alopecia areata: Impressive results using low-level laser therapy
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study
- Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata
- Baricitinib in Alopecia Areata
- Usefulness of high-frequency ultrasonography in the assessment of alopecia areata – comparison of ultrasound images with trichoscopic images
- Cannabinoids for the Treatment of Hair, Scalp, and Skin Disorders: A Systematic Review
- Why steroids may not always work in alopecia areata: elevated unoccupied glucocorticoid receptors and decreased levels of thioredoxin